Thanks to improvements in therapies and management, survival for patients with pulmonary arterial hypertension (PAH) has improved over the last 20 years. Unfortunately, patients with PAH and connective tissue disease (CTD)—especially systemic sclerosis—have not matched these outcomes. What is your role in closing this gap, even if you are not in a pulmonary hypertension specialty center? In this video roundtable, three experts in rheumatology and pulmonary medicine give you front-row access to their discussions on how rheumatology, pulmonology, and cardiology physicians, NPs, and PAs can collaborate to recognize and manage PAH early in this crucial patient population.
In Partnership With the Association of Pulmonary Advanced Practice Providers
In Partnership With the Society of Physician Assistants in Rheumatology
After completing this activity, participants should be better able to:
- Identify the symptoms and signs of CTD-PAH and the screening tools needed to refer patients for further evaluation and prompt initiation of treatment
- Describe current recommendations for the management of PAH and how they should be tailored to patients with CTD
Cardiologists, rheumatologists, pulmonologists, and NPs and PAs specializing in cardiology, rheumatology, and pulmonology
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation
Practicing Clinicians Exchange designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit.
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Daniel Thibodeau, MHP, PA-C, Eastern Virginia Medical School, Norfolk, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Kingman: advisory board/consultant: Actelion/Johnson & Johnson, Bayer, United Therapeutics.
Dr Steen: advisory board/consultant: Boehringer Ingelheim; Eicos; speakers bureau: Actelion/Janssen, Johnson & Johnson.
Dr Tapson: advisory board/consultant/research: Bayer, Bristol Myers Squibb, EKOS/BTG/Boston Scientific, Johnson & Johnson/Actelion/Janssen, Penumbra, United Therapeutics; advisory board: Thrombolex; speakers bureau: EKOS/BTG/Boston Scientific, Janssen.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: March 31, 2021
Expiration date: March 30, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 101420AC